Author Archives: Reflector

Clinical Trial Data Disclosure in Europe: EMA Biting Off More than It Can Chew?

Is the EMA biting off more than it can chew? Reflector The European Medicines Agency’s ambitions are huge – as befits a body with such huge responsibilities. But its capacities to achieve what it sets out to do are now falling ever shorter. The latest deficiency is revealed by its admission that it cannot meet […]
Posted in Europe, Global, Guest Blog, Op-Ed, R&D | Tagged , , , , | Leave a comment

Who Dares to Stop the European Transparency Bandwagon?

Who is Trying to Stop the European Transparency Bandwagon? Reflector, EPE, October 14 2013 The data-transparency bandwagon is rolling rapidly across Europe, energetically propelled by regulators, health campaigners, and generic manufacturers. Much of the research-based industry is stepping out of the way of what looks like an unstoppable juggernaut, hoping at best to nudge it […]
Posted in Europe, Global, Guest Blog, Regulatory | Tagged , , , , , | Leave a comment

Europe: New Device and Diagnostics Legislation Could Shake Up the Drug Industry

EuropeNew Device and Diagnostics Legislation Will Shake Up Drug Industry The shockwaves from the current European Union debates in Brussels on medical devices are are likely to echo through the medicines business over the next few years. This month, the European parliament’s health committee will reach its view on the two major proposals launched last […]
Posted in Europe, Op-Ed, Regulatory | Tagged , , , , | 1 Comment

Testing the Waters of Transatlantic Trade

Testing the Waters of Transatlantic Trade As the process gets underway to create the Transatlantic Trade and Investment Partnership (T-TIP), Reflector asks, what is the likelihood of drug firms – and patients – reaping any rewards from the negotiations? So ceremonial was the launch in July of the wide-ranging EU-US trade talks that one might […]
Posted in Europe, Global, Op-Ed, Regulatory | Tagged , , , | Leave a comment

European Pharma Gears Up for Horizon 2020

European Pharma Gears Up for Horizon 2020 The ink is not yet dry on the European Union’s Horizon 2020 agreement to invest some €70 billion ($92 bn) in research over the next seven years, and already contenders for funding are jostling for attention. Europe’s biggest drug industry association EFPIA scored something of a coup by […]
Posted in Europe, Global, Guest Blog, Op-Ed | Tagged , , , , , , | Leave a comment
  • Categories

  • Meta